Cargando…
Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme
BACKGROUND: Cervical cancer is the most common female cancer in Rwanda that, in 2011, became the first African country to implement a national vaccination programme against human papillomavirus (HPV). METHODS: To provide a robust baseline for future evaluations of vaccine effectiveness, cervical cel...
Autores principales: | Ngabo, Fidele, Franceschi, Silvia, Baussano, Iacopo, Umulisa, M. Chantal, Snijders, Peter J. F., Uyterlinde, Anne M., Lazzarato, Fulvio, Tenet, Vanessa, Gatera, Maurice, Binagwaho, Agnes, Clifford, Gary M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877733/ https://www.ncbi.nlm.nih.gov/pubmed/27221238 http://dx.doi.org/10.1186/s12879-016-1539-6 |
Ejemplares similares
-
Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda
por: Umulisa, M. Chantal, et al.
Publicado: (2018) -
Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort
por: Sayinzoga, Felix, et al.
Publicado: (2020) -
Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan
por: Baussano, Iacopo, et al.
Publicado: (2021) -
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys
por: Sayinzoga, Felix, et al.
Publicado: (2023) -
Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme
por: Tshomo, Ugyen, et al.
Publicado: (2014)